BGIM
AZN icon

Brandywine Global Investment Management’s AstraZeneca AZN Stock Holding History

Brandywine Global Investment Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.85M Sell
10,079
-200,181
-95% -$35.1M 0.01% 482
2025
Q3 		$32.3M Sell
210,260
-4,030
-2% -$610K 0.22% 130
2025
Q2 		$29.9M Buy
214,290
+2,149
+1% +$301K 0.21% 126
2025
Q1 		$31.2M Sell
212,141
-2,080
-1% -$301K 0.22% 120
2024
Q4 		$28.1M Buy
+214,221
New +$30M 0.2% 126
2024
Q1 		– Sell
-189,424
Closed -$25.5M – 705
2023
Q4 		$25.5M Buy
189,424
+14,299
+8% +$1.86M 0.21% 120
2023
Q3 		$23.7M Sell
175,125
-55,137
-24% -$7.53M 0.21% 125
2023
Q2 		$33M Sell
230,262
-6,894
-3% -$1.01M 0.27% 101
2023
Q1 		$32.9M Sell
237,156
-11,384
-5% -$1.53M 0.27% 108
2022
Q4 		$33.7M Sell
248,540
-13,100
-5% -$1.64M 0.26% 109
2022
Q3 		$28.7M Sell
261,640
-4,293
-2% -$545K 0.27% 104
2022
Q2 		$35.1M Sell
265,933
-16,180
-6% -$2.12M 0.31% 102
2022
Q1 		$37.4M Sell
282,113
-8,762
-3% -$1.05M 0.27% 106
2021
Q4 		$33.9M Sell
290,875
-165,262
-36% -$19.4M 0.24% 116
2021
Q3 		$54.8M Buy
456,137
+219,866
+93% +$25.6M 0.41% 63
2021
Q2 		$28.3M Buy
236,271
+23,509
+11% +$2.58M 0.21% 126
2021
Q1 		$21.2M Buy
212,762
+79,380
+60% +$7.98M 0.16% 159
2020
Q4 		$13.3M Sell
133,382
-20,550
-13% -$2.18M 0.11% 198
2020
Q3 		$16.9M Sell
153,932
-2,500
-2% -$278K 0.17% 140
2020
Q2 		$16.5M Sell
156,432
-78,175
-33% -$8.07M 0.17% 133
2020
Q1 		$21M Sell
234,607
-247,625
-51% -$23.3M 0.25% 93
2019
Q4 		$48.6M Sell
482,232
-16,200
-3% -$1.53M 0.34% 72
2019
Q3 		$44.4M Sell
498,432
-21,450
-4% -$1.86M 0.33% 74
2019
Q2 		$42.9M Buy
+519,882
New +$40.8M 0.3% 80

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Brandywine Global Investment Management's AZN Position: Q4 2025 in Review

Brandywine Global Investment Management reduced its AstraZeneca (AZN) stake by 95% in Q4 2025, selling an estimated $35.1M and leaving 10,079 shares worth $1.85M. The position accounts for 0.01% of the portfolio, ranked #482.

Brandywine Global Investment Management first reported a position in AZN in Q2 2019 and has held it in 24 quarters since. The position peaked at $54.8M in Q3 2021. 1,408 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

  • Brandywine Global Investment Management held 10,079 shares of AstraZeneca worth $1.85M as of Q4 2025.
  • Brandywine Global Investment Management sold 200,181 AstraZeneca shares in Q4 2025, an estimated $35.1M.
  • AstraZeneca made up 0.01% of Brandywine Global Investment Management's portfolio in Q4 2025, its #482 holding.
  • Brandywine Global Investment Management first reported a position in AstraZeneca in Q2 2019 and has held it in 24 quarters since.
  • Brandywine Global Investment Management's AstraZeneca position peaked at $54.8M in Q3 2021.
  • 1,408 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on Brandywine Global Investment Management's 13F filing for Q4 2025, filed 11 Feb 2026.